Key Points
- Bayview Legacy sold 2,116 shares of Arteris on Jan. 13 at $17.79 for $37,643.64; after the trade it still directly owns 9,416,955 shares (a 0.02% decrease) valued at about $167.5M.
- Bayview has been reducing its position with larger sales earlier in December and January—220,000 shares sold across four transactions (Dec. 4–8 and Jan. 8) for roughly $3.75M—indicating an ongoing pattern of insider selling.
- For context, Arteris has a market cap of about $758.7M, a 52‑week range of $5.46–$19.85, and a consensus analyst rating of "Moderate Buy" with a $17.50 price target.
Arteris, Inc. (NASDAQ:AIP - Get Free Report) major shareholder Bayview Legacy, Llc sold 2,116 shares of the firm's stock in a transaction that occurred on Tuesday, January 13th. The stock was sold at an average price of $17.79, for a total transaction of $37,643.64. Following the transaction, the insider directly owned 9,416,955 shares in the company, valued at $167,527,629.45. This represents a 0.02% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Major shareholders that own at least 10% of a company's stock are required to disclose their transactions with the SEC.
Bayview Legacy, Llc also recently made the following trade(s):
- On Thursday, January 8th, Bayview Legacy, Llc sold 50,000 shares of Arteris stock. The stock was sold at an average price of $16.58, for a total value of $829,000.00.
- On Monday, December 8th, Bayview Legacy, Llc sold 70,000 shares of Arteris stock. The stock was sold at an average price of $17.71, for a total value of $1,239,700.00.
- On Friday, December 5th, Bayview Legacy, Llc sold 60,000 shares of Arteris stock. The shares were sold at an average price of $17.08, for a total value of $1,024,800.00.
- On Thursday, December 4th, Bayview Legacy, Llc sold 40,000 shares of Arteris stock. The shares were sold at an average price of $16.46, for a total value of $658,400.00.
Arteris Stock Performance
Shares of NASDAQ AIP opened at $17.37 on Friday. The stock has a market capitalization of $758.72 million, a P/E ratio of -20.93 and a beta of 1.48. The stock's fifty day moving average is $15.68 and its 200 day moving average is $12.36. Arteris, Inc. has a 52 week low of $5.46 and a 52 week high of $19.85.
Arteris (NASDAQ:AIP - Get Free Report) last announced its quarterly earnings data on Tuesday, November 4th. The company reported ($0.09) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.11) by $0.02. The firm had revenue of $17.41 million for the quarter, compared to analyst estimates of $17.00 million. Equities research analysts forecast that Arteris, Inc. will post -0.73 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Several equities research analysts have weighed in on AIP shares. Jefferies Financial Group upgraded Arteris to a "hold" rating in a research note on Tuesday, October 28th. Cowen reaffirmed a "buy" rating on shares of Arteris in a research note on Wednesday, November 5th. Weiss Ratings reissued a "sell (d-)" rating on shares of Arteris in a research note on Wednesday, October 8th. Rosenblatt Securities reissued a "buy" rating and issued a $20.00 target price on shares of Arteris in a report on Monday, December 15th. Finally, TD Cowen lifted their price target on shares of Arteris from $15.00 to $16.50 and gave the company a "buy" rating in a report on Wednesday, November 5th. Four research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $17.50.
Get Our Latest Report on AIP
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the company. Acuitas Investments LLC acquired a new position in shares of Arteris during the second quarter worth $858,000. Worth Venture Partners LLC bought a new stake in shares of Arteris in the 2nd quarter valued at about $451,000. Franklin Resources Inc. grew its position in shares of Arteris by 9.6% in the 2nd quarter. Franklin Resources Inc. now owns 1,637,171 shares of the company's stock valued at $15,602,000 after buying an additional 142,936 shares during the last quarter. Squarepoint Ops LLC lifted its stake in shares of Arteris by 143.8% in the second quarter. Squarepoint Ops LLC now owns 120,957 shares of the company's stock worth $1,153,000 after acquiring an additional 71,340 shares during the period. Finally, Campbell & CO Investment Adviser LLC bought a new stake in Arteris in the second quarter valued at approximately $254,000. Institutional investors and hedge funds own 64.36% of the company's stock.
Arteris Company Profile
(
Get Free Report)
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company's core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
